Associations between male reproductive health and exposure to endocrine-disrupting chemicals

dc.contributor.authorRodprasert W.
dc.contributor.authorMain K.
dc.contributor.authorToppari J.
dc.contributor.authorVirtanen H.
dc.contributor.organizationfi=biolääketieteen laitos|en=Institute of Biomedicine|
dc.contributor.organizationfi=lastentautioppi|en=Paediatrics and Adolescent Medicine|
dc.contributor.organizationfi=tyks, vsshp|en=tyks, varha|
dc.contributor.organization-code1.2.246.10.2458963.20.77952289591
dc.converis.publication-id42294221
dc.converis.urlhttps://research.utu.fi/converis/portal/Publication/42294221
dc.date.accessioned2022-10-28T13:51:44Z
dc.date.available2022-10-28T13:51:44Z
dc.description.abstract<p>The incidence of many male reproductive disorders, including cryptorchidism and testicular cancer has increased. Semen quality in several countries has declined. Exposure to endocrine-disrupting chemicals (EDCs) — both prenatal and postnatal — has been proposed to have a role in these trends based on experimental data and animal studies. There is epidemiological evidence for an association between prenatal exposure to EDCs and cryptorchidism, hypospadias, and decreased anogenital distance, as well as an association between an exposure to EDCs in adulthood and semen quality. However, some of these findings are inconsistent across studies. There is less evidence about the role of prenatal exposure to EDCs for semen quality, and only few studies have investigated the role of prenatal EDC exposure in testicular cancer occurrence. This is due to a lack of long-term follow-up studies linking prenatal exposures with male reproductive disorders in adulthood. More research is needed investigating the role of EDC exposure for male reproductive health, particularly long-term follow-up studies to assess the outcomes in adulthood.<br /></p>
dc.format.pagerange49
dc.format.pagerange61
dc.identifier.olddbid184806
dc.identifier.oldhandle10024/167900
dc.identifier.urihttps://www.utupub.fi/handle/11111/51620
dc.identifier.urlhttps://www.sciencedirect.com/science/article/pii/S2451965019300043
dc.identifier.urnURN:NBN:fi-fe2021042823937
dc.language.isoen
dc.okm.affiliatedauthorRodprasert, Wiwat
dc.okm.affiliatedauthorToppari, Jorma
dc.okm.affiliatedauthorDataimport, Lastentautioppi
dc.okm.affiliatedauthorVirtanen, Helena
dc.okm.affiliatedauthorDataimport, tyks, vsshp
dc.okm.discipline1184 Genetics, developmental biology, physiologyen_GB
dc.okm.discipline3122 Cancersen_GB
dc.okm.discipline1184 Genetiikka, kehitysbiologia, fysiologiafi_FI
dc.okm.discipline3122 Syöpätauditfi_FI
dc.okm.internationalcopublicationinternational co-publication
dc.okm.internationalityInternational publication
dc.okm.typeA2 Scientific Article
dc.publisherElsevier Ltd
dc.publisher.countryUnited Kingdomen_GB
dc.publisher.countryBritanniafi_FI
dc.publisher.country-codeGB
dc.relation.doi10.1016/j.coemr.2019.05.002
dc.relation.ispartofjournalCurrent Opinion in Endocrine and Metabolic Research
dc.relation.volume7
dc.source.identifierhttps://www.utupub.fi/handle/10024/167900
dc.titleAssociations between male reproductive health and exposure to endocrine-disrupting chemicals
dc.year.issued2019

Tiedostot

Näytetään 1 - 1 / 1
Ladataan...
Name:
1-s2.0-S2451965019300043-main.pdf
Size:
489.74 KB
Format:
Adobe Portable Document Format
Description:
Publisher's PDF